Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Impact of Meat Intake on Bladder Cancer Incidence: Is It Really a Relevant Risk?
Aveta A, Cacciapuoti C, Barone B, Di Zazzo E, Del Giudice F, Maggi M, Ferro M, Terracciano D, Busetto GM, Lucarelli G, Tataru OS, Montanari E, Mirto BF, Falcone A, Giampaglia G, Sicignano E, Capone F, Villano G, Angellotto P, Manfredi C, Napolitano L, Imbimbo C, Pandolfo SD, Crocetto F. Aveta A, et al. Among authors: tataru os. Cancers (Basel). 2022 Sep 29;14(19):4775. doi: 10.3390/cancers14194775. Cancers (Basel). 2022. PMID: 36230700 Free PMC article. Review.
Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management-Current Trends and Future Perspectives.
Tătaru OS, Vartolomei MD, Rassweiler JJ, Virgil O, Lucarelli G, Porpiglia F, Amparore D, Manfredi M, Carrieri G, Falagario U, Terracciano D, de Cobelli O, Busetto GM, Del Giudice F, Ferro M. Tătaru OS, et al. Diagnostics (Basel). 2021 Feb 20;11(2):354. doi: 10.3390/diagnostics11020354. Diagnostics (Basel). 2021. PMID: 33672608 Free PMC article. Review.
Prostate Cancer Radiogenomics-From Imaging to Molecular Characterization.
Ferro M, de Cobelli O, Vartolomei MD, Lucarelli G, Crocetto F, Barone B, Sciarra A, Del Giudice F, Muto M, Maggi M, Carrieri G, Busetto GM, Falagario U, Terracciano D, Cormio L, Musi G, Tataru OS. Ferro M, et al. Among authors: tataru os. Int J Mol Sci. 2021 Sep 15;22(18):9971. doi: 10.3390/ijms22189971. Int J Mol Sci. 2021. PMID: 34576134 Free PMC article. Review.
Fascin-1 and its role as a serological marker in prostate cancer: a prospective case-control study.
Tătaru OS, Martha O, Crocetto F, Barone B, Voidazan S, Borda A, Sin A, Hutanu A, Loghin A, Sin I, Porav-Hodade D, Chibelean CB, Vartolomei L, Lucarelli G, Ferro M, Osan VG, Buonerba C, Vartolomei MD. Tătaru OS, et al. Future Sci OA. 2021 Jun 30;7(9):FSO745. doi: 10.2144/fsoa-2021-0051. eCollection 2021 Oct. Future Sci OA. 2021. PMID: 34737886 Free PMC article.
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette-Guerin Immunotherapy.
Ferro M, Tătaru OS, Musi G, Lucarelli G, Abu Farhan AR, Cantiello F, Damiano R, Hurle R, Contieri R, Busetto GM, Carrieri G, Cormio L, Del Giudice F, Sciarra A, Perdonà S, Borghesi M, Terrone C, La Civita E, Bove P, Autorino R, Muto M, Crisan N, Marchioni M, Schips L, Soria F, Terracciano D, Papalia R, Crocetto F, Barone B, Russo GI, Luzzago S, Ludovico GM, Vartolomei MD, Mistretta FA, Mirone V, de Cobelli O. Ferro M, et al. Among authors: tataru os. Diagnostics (Basel). 2022 Feb 25;12(3):586. doi: 10.3390/diagnostics12030586. Diagnostics (Basel). 2022. PMID: 35328139 Free PMC article.
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer.
Ferro M, Barone B, Crocetto F, Lucarelli G, Busetto GM, Del Giudice F, Maggi M, Crocerossa F, Cantiello F, Damiano R, Borghesi M, Bove PL, Papalia R, Mari A, Luzzago S, Soria F, Marchioni M, La Civita E, Terracciano D, Mistretta FA, Piccinelli M, Marmiroli A, Russo GI, Schips L, Hurle R, Contieri R, Perdonà S, Del Prete P, Mirone V, Tataru OS, Musi G, Montanari E, de Cobelli O, Vartolomei MD. Ferro M, et al. Among authors: tataru os. Urol Oncol. 2022 Nov;40(11):490.e13-490.e20. doi: 10.1016/j.urolonc.2022.05.016. Epub 2022 Jun 5. Urol Oncol. 2022. PMID: 35676172
Radiomics in prostate cancer: an up-to-date review.
Ferro M, de Cobelli O, Musi G, Del Giudice F, Carrieri G, Busetto GM, Falagario UG, Sciarra A, Maggi M, Crocetto F, Barone B, Caputo VF, Marchioni M, Lucarelli G, Imbimbo C, Mistretta FA, Luzzago S, Vartolomei MD, Cormio L, Autorino R, Tătaru OS. Ferro M, et al. Among authors: tataru os. Ther Adv Urol. 2022 Jul 4;14:17562872221109020. doi: 10.1177/17562872221109020. eCollection 2022 Jan-Dec. Ther Adv Urol. 2022. PMID: 35814914 Free PMC article. Review.
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG.
Contieri R, Hurle R, Paciotti M, Casale P, Saita A, Porpiglia F, Fiori C, Barone B, Crocetto F, Lucarelli G, Busetto GM, Del Giudice F, Maggi M, Cantiello F, Damiano R, Borghesi M, Bove P, Bertolo R, Papalia R, Mari A, Luzzago S, Mistretta FA, Soria F, Gontero P, Marchioni M, LA Civita E, Terracciano D, Russo GI, Schips L, Perdona S, Mirone V, Tataru OS, Musi G, Vartolomei MD, Autorino R, Montanari E, DE Cobelli O, Ferro M. Contieri R, et al. Among authors: tataru os. Minerva Urol Nephrol. 2023 Apr;75(2):180-187. doi: 10.23736/S2724-6051.22.04953-9. Epub 2022 Oct 5. Minerva Urol Nephrol. 2023. PMID: 36197700 Free article.
Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer.
Lasorsa F, di Meo NA, Rutigliano M, Ferro M, Terracciano D, Tataru OS, Battaglia M, Ditonno P, Lucarelli G. Lasorsa F, et al. Among authors: tataru os. Int J Mol Sci. 2023 Jan 4;24(2):910. doi: 10.3390/ijms24020910. Int J Mol Sci. 2023. PMID: 36674430 Free PMC article. Review.
23 results